News
Bristol Myers Squibb has declared a quarterly dividend of $0.62 per share, maintaining its impressive 55-year streak of ...
FARGO, N.D. (KVRR) –Nearly seventy years ago, Roger Maris stepped onto the major league field to play baseball. And this week, his sons are sharing his legacy with a new generation of kids for the ...
A resolution currently under consideration by the Oregon House signals "to those potential buyers that lawmakers are excited ...
Fraser’s friend Hugh Porter sadly passed away from non-Hodgkin lymphoma, a type of blood cancer. Back in 2020, Hugh took on ...
New Jersey has long been recognized as the “Medicine Chest of the World” and ranks as the ninth largest med-tech hub in the ...
Epcoritamab Plus Chemoimmunotherapy Yields 87% Response Rate in R/R DLBCL; 65% Proceed to Transplant
Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...
Breyanzi demonstrated a 95.5% response rate among patients with relapsed/refractory marginal zone lymphoma, as well as a ...
A husband and wife who were twice diagnosed with cancer within months of each other are urging people to join Race for Life and support life-saving research into the disease.
A study published last year by Swedish researchers found tattoos can increase your risk of a deadly blood cancer, and the ...
Amit Mookim, CEO, Immuneel Therapeutics, highlights the burden of blood cancer in India and how government policies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results